Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial

Highlights ► HFMD outbreaks cause high mortality in mainland China since 2008. ► Enterovirus 71 (EV71) was associated with high-mortality HFMD outbreaks. ► EV71 vaccine will be the most effective measure to reduce morbidity and mortality. ► The Phase I clinical study evaluated safety and immunogenic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2012-05, Vol.30 (22), p.3295-3303
Hauptverfasser: Li, Yan-Ping, Liang, Zheng-Lun, Gao, Qiang, Huang, Li-Rong, Mao, Qun-Ying, Wen, Shu-Qun, Liu, Yan, Yin, Wei-Dong, Li, Rong-Cheng, Wang, Jun-Zhi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights ► HFMD outbreaks cause high mortality in mainland China since 2008. ► Enterovirus 71 (EV71) was associated with high-mortality HFMD outbreaks. ► EV71 vaccine will be the most effective measure to reduce morbidity and mortality. ► The Phase I clinical study evaluated safety and immunogenicity of EV71 vaccine. ► EV71 was well tolerated and highly immunogenic in healthy subjects.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.03.010